美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Avalyn Pharma

28.11

+1.485.56%

盘后：28.110.00000.00%16:10 EDT

成交量：12.61万

成交额：350.16万

市值：11.75亿

市盈率：-13.79

高：28.61

开：26.75

低：26.00

收：26.63

52周最高：32.23

52周最低：25.05

股本：4,181.20万

流通股本：1,666.67万

量比：0.41

换手率：0.76%

股息：- -

股息率：- -

每股收益(TTM):-2.0380

净资产收益率：-68.34%

总资产收益率：-41.74%

市净率：-4.92

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Avalyn Pharma

交易所：

NASDAQ

成立时间：

2010

员工人数：

50

公司地址：

105 W First Street,Boston,Massachusetts,United States

官网：

http://www.avalynpharma.com

邮编：

02127

电话：

传真：

- -

简介：

Avalyn Pharma Inc.于2011年5月27日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，开发吸入药物以治疗罕见的呼吸道疾病，包括进行性肺纤维化、特发性肺纤维化和其他间质性肺部疾病。

董事

名称

职位

Lyn Baranowski

Chief Executive Officer,Director and President

David Friedman

Independent Director

Erin Lavelle

Independent Director

Heather Turner

Board Chair and Director

Jill Carroll

Independent Director

Jon Congleton

Independent Director

Kate Haviland

Independent Director

股东

名称

职位

Lyn Baranowski

Chief Executive Officer,Director and President

Melissa Rhodes

Chief Operating Officer

Douglas Carlson

Chief Business Officer and Chief Financial Officer

Adam Golden

General Counsel

Howard M. Lazarus

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AVLN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":28.11,"timestamp":1779220800000,"preClose":26.63,"halted":0,"volume":126141,"hourTrading":{"tag":"盘后","latestPrice":28.11,"preClose":28.11,"latestTime":"16:10 EDT","volume":9,"amount":252.99,"timestamp":1779221404333,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0555764175741645,"floatShares":16666700,"shares":41812047,"eps":-2.038,"marketStatus":"未开盘","change":1.48,"latestTime":"05-19 16:00:00 EDT","open":26.75,"high":28.61,"low":26,"amount":3501633.1842,"amplitude":0.09801,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.038,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":0,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":26.63,"postHourTrading":{"tag":"盘后","latestPrice":28.11,"preClose":28.11,"latestTime":"16:10 EDT","volume":9,"amount":252.99,"timestamp":1779221404333,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.413718},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":0,"volumeRatio":0.413718,"shares":41812047,"dividePrice":0,"high":28.61,"amplitude":0.09801,"preClose":26.63,"low":26,"week52Low":25.05,"pbRate":"-4.92","week52High":32.225,"institutionHeld":0,"latestPrice":28.11,"eps":-2.038,"divideRate":0,"volume":126141,"delay":0,"ttmEps":-2.038,"open":26.75,"prevYearClose":18,"prevWeekClose":29.84,"prevMonthClose":29.49,"prevQuarterClose":18,"fiveDayClose":29.9,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-05-18","current":-13.792934,"percent":0.25,"low":-15.129165,"twenty":-14.66101,"median":-14.471589,"eighty":-13.431244,"high":-8.833116,"avg":-13.837039,"sd":1.567162,"marketCap":1247671482},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-18","current":-14.643344,"twenty":-14.66101,"median":-14.471589,"eighty":-13.431244,"marketCap":1247671482}],"updateTime":1779254579455},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":224094665,"yearFounded":2010,"employeeNum":50,"address":"105 W First Street,Boston,Massachusetts,United States","zipCode":"02127","officePhone":"(206) 707-0340","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.avalynpharma.com","stockEarnings":[{"period":"1week","weight":-0.0599},{"period":"1month","weight":0.5617},{"period":"ytd","weight":0.5617}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0691},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.2335},{"period":"ytd","weight":0.076}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avalyn Pharma Inc.于2011年5月27日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，开发吸入药物以治疗罕见的呼吸道疾病，包括进行性肺纤维化、特发性肺纤维化和其他间质性肺部疾病。","exchange":"NASDAQ","name":"Avalyn Pharma","nameEN":"Avalyn Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":{"directors":[{"name":"Lyn Baranowski","position":"Chief Executive Officer,Director and President"},{"name":"David Friedman","position":"Independent Director"},{"name":"Erin Lavelle","position":"Independent Director"},{"name":"Heather Turner","position":"Board Chair and Director"},{"name":"Jill Carroll","position":"Independent Director"},{"name":"Jon Congleton","position":"Independent Director"},{"name":"Kate Haviland","position":"Independent Director"}],"executives":[{"name":"Lyn Baranowski","position":"Chief Executive Officer,Director and President"},{"name":"Melissa Rhodes","position":"Chief Operating Officer"},{"name":"Douglas Carlson","position":"Chief Business Officer and Chief Financial Officer"},{"name":"Adam Golden","position":"General Counsel"},{"name":"Howard M. Lazarus","position":"Chief Medical Officer"}]}}}